Found 33 hits with Last Name = 'panula' and Initial = 'p' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86140
(CAS_123797 | NPFF | NSC_123797)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=O)-[#6](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6]-1-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.130 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Prolactin-releasing peptide receptor
(Homo sapiens (Human)) | BDBM86139
(CAS_235433-36-0 | CAS_99566-27-5 | NPSF | NSC_0 | ...)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O |r| Show InChI InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 | UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.680 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Prolactin-releasing peptide receptor
(Homo sapiens (Human)) | BDBM86148
(CAS_222988-10-5 | PrRP20)Show SMILES CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:31.40,57.60,77.81,101.106,89.92,111.115,96.101,98.104,125.131,151.156,wD:43.56,27.27,62.64,105.111,69.77,12.19,81.89,4.4,2.2,129.134,140.145,(11.09,9.04,;9.83,9.87,;8.5,9.19,;8.39,7.7,;7.21,10.07,;5.85,9.36,;5.77,7.85,;7.06,7,;4.44,7.12,;4.34,5.63,;3.08,4.78,;1.87,5.53,;3.05,3.19,;4.36,2.33,;5.77,3.06,;7.06,2.26,;8.39,2.96,;9.71,2.08,;11.09,2.81,;9.68,.54,;1.69,2.51,;1.51,1,;2.75,.16,;.1,.26,;.05,-1.27,;-1.31,-1.95,;-2.57,-1.1,;-1.39,-3.47,;-2.72,-4.12,;-2.72,-5.66,;-1.39,-6.52,;-4.11,-6.37,;-5.39,-5.51,;-5.32,-3.97,;-6.6,-3.14,;-6.45,-1.58,;-5.09,-.92,;-4.94,.64,;-3.83,-1.75,;-3.93,-3.34,;-4.16,-7.88,;-5.52,-8.56,;-6.81,-7.75,;-5.57,-10.1,;-4.29,-10.95,;-2.92,-10.2,;-2.77,-8.68,;-1.26,-8.31,;-.45,-9.67,;1.03,-10.02,;1.56,-11.53,;.45,-12.54,;-1.06,-12.34,;-1.56,-10.85,;-6.91,-10.8,;-6.93,-12.34,;-5.65,-13.2,;-8.27,-13.1,;-9.63,-12.24,;-8.37,-14.63,;-9.81,-15.21,;-11.14,-14.36,;-9.93,-16.68,;-8.77,-17.76,;-9.48,-19.17,;-11.02,-18.99,;-11.27,-17.46,;-12.68,-16.85,;-12.68,-15.42,;-13.96,-17.66,;-13.99,-19.2,;-12.6,-19.98,;-11.27,-19.17,;-12.6,-21.46,;-15.33,-16.85,;-16.71,-17.58,;-16.66,-19.1,;-18.05,-16.8,;-19.36,-17.58,;-20.67,-16.75,;-20.67,-15.21,;-22.01,-17.53,;-22.03,-19.12,;-20.67,-19.85,;-19.33,-19.07,;-20.67,-21.44,;-23.37,-16.78,;-24.65,-17.63,;-24.65,-19.3,;-25.99,-16.9,;-26.24,-15.39,;-27.78,-15.14,;-28.54,-16.55,;-27.38,-17.63,;-27.58,-19.2,;-26.37,-20.08,;-29.04,-19.8,;-29.19,-21.39,;-30.33,-18.87,;-31.76,-19.5,;-30.15,-17.33,;-18.05,-15.26,;-19.38,-14.46,;-16.71,-14.51,;-16.69,-12.92,;-.13,-4.3,;-.2,-5.81,;1.24,-3.62,;7.26,11.53,;6.05,12.36,;8.62,12.21,;8.65,13.7,;7.36,14.63,;7.44,16.2,;6.2,17.03,;6.28,18.57,;4.94,19.45,;5.04,21.01,;3.5,18.77,;10.08,14.48,;11.29,13.65,;10.31,15.99,;9.2,17.08,;9.93,18.46,;11.44,18.24,;11.7,16.75,;12.98,15.99,;12.98,14.41,;14.29,16.85,;15.6,16.1,;15.63,14.58,;14.32,13.75,;16.94,13.8,;16.89,16.88,;16.86,18.41,;18.2,16.12,;19.49,16.85,;20.85,16.12,;20.82,14.66,;22.21,16.8,;23.52,16.02,;23.49,14.43,;24.86,13.62,;24.83,12.14,;26.12,11.33,;26.09,9.79,;27.4,8.99,;24.78,9.01,;24.88,16.8,;24.88,18.26,;26.24,16.12,;27.6,16.85,;27.63,18.36,;28.99,19.2,;30.33,18.34,;31.74,19.12,;31.76,20.66,;30.45,21.46,;29.04,20.71,;28.89,16.12,;30.15,16.98,;28.86,14.48,)| Show InChI InChI=1S/C104H158N32O26/c1-10-53(5)82(97(158)124-66(29-19-39-116-104(112)113)99(160)134-40-21-32-74(134)94(155)131-81(52(3)4)95(156)119-49-77(142)123-65(28-18-38-115-103(110)111)88(149)125-67(85(107)146)43-58-23-13-12-14-24-58)130-78(143)51-118-87(148)64(27-17-37-114-102(108)109)122-76(141)50-120-96(157)84(57(9)138)133-90(151)68(44-59-33-35-61(139)36-34-59)127-89(150)69(45-60-48-117-63-26-16-15-25-62(60)63)126-86(147)55(7)121-92(153)72-30-20-41-135(72)100(161)71(46-75(105)140)129-98(159)83(54(6)11-2)132-91(152)70(47-79(144)145)128-93(154)73-31-22-42-136(73)101(162)80(106)56(8)137/h12-16,23-26,33-36,48,52-57,64-74,80-84,117,137-139H,10-11,17-22,27-32,37-47,49-51,106H2,1-9H3,(H2,105,140)(H2,107,146)(H,118,148)(H,119,156)(H,120,157)(H,121,153)(H,122,141)(H,123,142)(H,124,158)(H,125,149)(H,126,147)(H,127,150)(H,128,154)(H,129,159)(H,130,143)(H,131,155)(H,132,152)(H,133,151)(H,144,145)(H4,108,109,114)(H4,110,111,115)(H4,112,113,116)/t53-,54-,55-,56+,57+,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,80-,81-,82-,83-,84-/m0/s1 | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86147
(CAS_68615 | FMRFamide | NSC_68615)Show SMILES [#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=O)-[#6](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C29H42N8O4S/c1-42-16-14-23(35-26(39)21(30)17-19-9-4-2-5-10-19)28(41)36-22(13-8-15-34-29(32)33)27(40)37-24(25(31)38)18-20-11-6-3-7-12-20/h2-7,9-12,21-24H,8,13-18,30H2,1H3,(H2,31,38)(H,35,39)(H,36,41)(H,37,40)(H4,32,33,34) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86148
(CAS_222988-10-5 | PrRP20)Show SMILES CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:31.40,57.60,77.81,101.106,89.92,111.115,96.101,98.104,125.131,151.156,wD:43.56,27.27,62.64,105.111,69.77,12.19,81.89,4.4,2.2,129.134,140.145,(11.09,9.04,;9.83,9.87,;8.5,9.19,;8.39,7.7,;7.21,10.07,;5.85,9.36,;5.77,7.85,;7.06,7,;4.44,7.12,;4.34,5.63,;3.08,4.78,;1.87,5.53,;3.05,3.19,;4.36,2.33,;5.77,3.06,;7.06,2.26,;8.39,2.96,;9.71,2.08,;11.09,2.81,;9.68,.54,;1.69,2.51,;1.51,1,;2.75,.16,;.1,.26,;.05,-1.27,;-1.31,-1.95,;-2.57,-1.1,;-1.39,-3.47,;-2.72,-4.12,;-2.72,-5.66,;-1.39,-6.52,;-4.11,-6.37,;-5.39,-5.51,;-5.32,-3.97,;-6.6,-3.14,;-6.45,-1.58,;-5.09,-.92,;-4.94,.64,;-3.83,-1.75,;-3.93,-3.34,;-4.16,-7.88,;-5.52,-8.56,;-6.81,-7.75,;-5.57,-10.1,;-4.29,-10.95,;-2.92,-10.2,;-2.77,-8.68,;-1.26,-8.31,;-.45,-9.67,;1.03,-10.02,;1.56,-11.53,;.45,-12.54,;-1.06,-12.34,;-1.56,-10.85,;-6.91,-10.8,;-6.93,-12.34,;-5.65,-13.2,;-8.27,-13.1,;-9.63,-12.24,;-8.37,-14.63,;-9.81,-15.21,;-11.14,-14.36,;-9.93,-16.68,;-8.77,-17.76,;-9.48,-19.17,;-11.02,-18.99,;-11.27,-17.46,;-12.68,-16.85,;-12.68,-15.42,;-13.96,-17.66,;-13.99,-19.2,;-12.6,-19.98,;-11.27,-19.17,;-12.6,-21.46,;-15.33,-16.85,;-16.71,-17.58,;-16.66,-19.1,;-18.05,-16.8,;-19.36,-17.58,;-20.67,-16.75,;-20.67,-15.21,;-22.01,-17.53,;-22.03,-19.12,;-20.67,-19.85,;-19.33,-19.07,;-20.67,-21.44,;-23.37,-16.78,;-24.65,-17.63,;-24.65,-19.3,;-25.99,-16.9,;-26.24,-15.39,;-27.78,-15.14,;-28.54,-16.55,;-27.38,-17.63,;-27.58,-19.2,;-26.37,-20.08,;-29.04,-19.8,;-29.19,-21.39,;-30.33,-18.87,;-31.76,-19.5,;-30.15,-17.33,;-18.05,-15.26,;-19.38,-14.46,;-16.71,-14.51,;-16.69,-12.92,;-.13,-4.3,;-.2,-5.81,;1.24,-3.62,;7.26,11.53,;6.05,12.36,;8.62,12.21,;8.65,13.7,;7.36,14.63,;7.44,16.2,;6.2,17.03,;6.28,18.57,;4.94,19.45,;5.04,21.01,;3.5,18.77,;10.08,14.48,;11.29,13.65,;10.31,15.99,;9.2,17.08,;9.93,18.46,;11.44,18.24,;11.7,16.75,;12.98,15.99,;12.98,14.41,;14.29,16.85,;15.6,16.1,;15.63,14.58,;14.32,13.75,;16.94,13.8,;16.89,16.88,;16.86,18.41,;18.2,16.12,;19.49,16.85,;20.85,16.12,;20.82,14.66,;22.21,16.8,;23.52,16.02,;23.49,14.43,;24.86,13.62,;24.83,12.14,;26.12,11.33,;26.09,9.79,;27.4,8.99,;24.78,9.01,;24.88,16.8,;24.88,18.26,;26.24,16.12,;27.6,16.85,;27.63,18.36,;28.99,19.2,;30.33,18.34,;31.74,19.12,;31.76,20.66,;30.45,21.46,;29.04,20.71,;28.89,16.12,;30.15,16.98,;28.86,14.48,)| Show InChI InChI=1S/C104H158N32O26/c1-10-53(5)82(97(158)124-66(29-19-39-116-104(112)113)99(160)134-40-21-32-74(134)94(155)131-81(52(3)4)95(156)119-49-77(142)123-65(28-18-38-115-103(110)111)88(149)125-67(85(107)146)43-58-23-13-12-14-24-58)130-78(143)51-118-87(148)64(27-17-37-114-102(108)109)122-76(141)50-120-96(157)84(57(9)138)133-90(151)68(44-59-33-35-61(139)36-34-59)127-89(150)69(45-60-48-117-63-26-16-15-25-62(60)63)126-86(147)55(7)121-92(153)72-30-20-41-135(72)100(161)71(46-75(105)140)129-98(159)83(54(6)11-2)132-91(152)70(47-79(144)145)128-93(154)73-31-22-42-136(73)101(162)80(106)56(8)137/h12-16,23-26,33-36,48,52-57,64-74,80-84,117,137-139H,10-11,17-22,27-32,37-47,49-51,106H2,1-9H3,(H2,105,140)(H2,107,146)(H,118,148)(H,119,156)(H,120,157)(H,121,153)(H,122,141)(H,123,142)(H,124,158)(H,125,149)(H,126,147)(H,127,150)(H,128,154)(H,129,159)(H,130,143)(H,131,155)(H,132,152)(H,133,151)(H,144,145)(H4,108,109,114)(H4,110,111,115)(H4,112,113,116)/t53-,54-,55-,56+,57+,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,80-,81-,82-,83-,84-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86139
(CAS_235433-36-0 | CAS_99566-27-5 | NPSF | NSC_0 | ...)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O |r| Show InChI InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86140
(CAS_123797 | NPFF | NSC_123797)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=O)-[#6](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6]-1-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61) | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86142
(1DMe-Y8Fa | CAS_132709 | NSC_132709)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6](-[#7](-[#6])-[#6](=O)-[#6](-[#7])-[#6]-c1ccc(-[#8])cc1)-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6]-1-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C55H78N14O11/c1-32(2)28-44(68(3)53(79)37(56)29-35-18-20-36(70)21-19-35)52(78)67-42(31-34-14-8-5-9-15-34)50(76)65-40(23-25-46(58)72)54(80)69-27-11-17-43(69)51(77)64-39(22-24-45(57)71)49(75)63-38(16-10-26-62-55(60)61)48(74)66-41(47(59)73)30-33-12-6-4-7-13-33/h4-9,12-15,18-21,32,37-44,70H,10-11,16-17,22-31,56H2,1-3H3,(H2,57,71)(H2,58,72)(H2,59,73)(H,63,75)(H,64,77)(H,65,76)(H,66,74)(H,67,78)(H4,60,61,62) | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.30 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86139
(CAS_235433-36-0 | CAS_99566-27-5 | NPSF | NSC_0 | ...)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O |r| Show InChI InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 5.90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86146
(CAS_0 | NSC_0 | PrRP24-31)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7])-[#6](-[#6])-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O |r| Show InChI InChI=1S/C42H67N13O9/c1-23(2)19-29(53-37(60)28(21-32(43)56)52-39(62)31-15-10-18-55(31)41(64)34(44)24(3)4)40(63)54-17-9-14-30(54)38(61)49-22-33(57)50-26(13-8-16-48-42(46)47)36(59)51-27(35(45)58)20-25-11-6-5-7-12-25/h5-7,11-12,23-24,26-31,34H,8-10,13-22,44H2,1-4H3,(H2,43,56)(H2,45,58)(H,49,61)(H,50,57)(H,51,59)(H,52,62)(H,53,60)(H4,46,47,48)/t26-,27-,28-,29-,30-,31-,34-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 11 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86147
(CAS_68615 | FMRFamide | NSC_68615)Show SMILES [#6]-[#16]-[#6]-[#6]-[#6](-[#7]-[#6](=O)-[#6](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C29H42N8O4S/c1-42-16-14-23(35-26(39)21(30)17-19-9-4-2-5-10-19)28(41)36-22(13-8-15-34-29(32)33)27(40)37-24(25(31)38)18-20-11-6-3-7-12-20/h2-7,9-12,21-24H,8,13-18,30H2,1H3,(H2,31,38)(H,35,39)(H,36,41)(H,37,40)(H4,32,33,34) | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86145
(L-Met-L-Pro-L-His-L-Serr-L-Phe-L-Ala-L-Asn-L-Leu-L...)Show SMILES CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |wU:61.65,65.68,42.44,26.27,16.16,12.13,4.4,wD:50.52,73.76,37.40,84.87,(38.04,3.65,;37.72,2.14,;36.25,1.67,;35.93,.16,;34.47,-.32,;33.33,.71,;34.15,-1.82,;32.68,-2.3,;35.29,-2.85,;36.8,-2.53,;37.57,-3.87,;36.54,-5.01,;35.13,-4.39,;33.8,-5.16,;32.47,-4.39,;33.8,-6.7,;32.47,-7.47,;32.47,-9.01,;33.8,-9.78,;33.96,-11.31,;35.47,-11.63,;36.24,-10.29,;35.21,-9.15,;31.13,-6.7,;31.13,-5.16,;29.8,-7.47,;28.46,-6.7,;27.13,-7.47,;27.13,-9.01,;25.8,-9.78,;25.8,-11.32,;27.13,-12.09,;28.46,-11.32,;28.46,-9.78,;28.46,-5.16,;29.8,-4.39,;27.13,-4.39,;27.13,-2.85,;28.46,-2.08,;25.8,-2.08,;24.46,-2.85,;25.8,-.54,;24.46,.23,;23.13,-.54,;21.8,.23,;21.8,1.77,;20.46,-.54,;24.46,1.77,;25.8,2.54,;23.13,2.54,;23.13,4.08,;24.46,4.85,;24.46,6.39,;25.8,7.16,;23.13,7.16,;21.8,4.85,;21.8,6.39,;20.46,4.08,;20.3,2.55,;18.79,2.23,;18.02,3.57,;19.05,4.71,;18.73,6.22,;19.88,7.25,;17.27,6.69,;16.13,5.66,;16.45,4.16,;15.3,3.13,;15.62,1.62,;13.84,3.6,;14.66,6.14,;14.34,7.65,;13.52,5.11,;12.05,5.58,;11.73,7.09,;10.27,7.57,;9.95,9.07,;8.48,9.55,;8.16,11.06,;6.7,11.53,;9.31,12.09,;10.91,4.55,;11.23,3.05,;9.44,5.03,;8.3,4,;6.83,4.47,;5.69,3.44,;4.22,3.92,;3.08,2.89,;3.4,1.38,;4.86,.91,;6.01,1.94,;8.62,2.49,;7.47,1.46,;10.08,2.02,)| Show InChI InChI=1S/C64H96N18O12S/c1-36(2)28-45(57(88)74-43(20-13-24-71-64(68)69)55(86)75-44(53(67)84)30-39-16-9-7-10-17-39)78-61(92)51-22-15-26-82(51)63(94)49(29-37(3)4)80-59(90)48(33-52(66)83)76-54(85)38(5)73-56(87)46(31-40-18-11-8-12-19-40)77-58(89)47(32-41-34-70-35-72-41)79-60(91)50-21-14-25-81(50)62(93)42(65)23-27-95-6/h7-12,16-19,34-38,42-51H,13-15,20-33,65H2,1-6H3,(H2,66,83)(H2,67,84)(H,70,72)(H,73,87)(H,74,88)(H,75,86)(H,76,85)(H,77,89)(H,78,92)(H,79,91)(H,80,90)(H4,68,69,71)/t38-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86145
(L-Met-L-Pro-L-His-L-Serr-L-Phe-L-Ala-L-Asn-L-Leu-L...)Show SMILES CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |wU:61.65,65.68,42.44,26.27,16.16,12.13,4.4,wD:50.52,73.76,37.40,84.87,(38.04,3.65,;37.72,2.14,;36.25,1.67,;35.93,.16,;34.47,-.32,;33.33,.71,;34.15,-1.82,;32.68,-2.3,;35.29,-2.85,;36.8,-2.53,;37.57,-3.87,;36.54,-5.01,;35.13,-4.39,;33.8,-5.16,;32.47,-4.39,;33.8,-6.7,;32.47,-7.47,;32.47,-9.01,;33.8,-9.78,;33.96,-11.31,;35.47,-11.63,;36.24,-10.29,;35.21,-9.15,;31.13,-6.7,;31.13,-5.16,;29.8,-7.47,;28.46,-6.7,;27.13,-7.47,;27.13,-9.01,;25.8,-9.78,;25.8,-11.32,;27.13,-12.09,;28.46,-11.32,;28.46,-9.78,;28.46,-5.16,;29.8,-4.39,;27.13,-4.39,;27.13,-2.85,;28.46,-2.08,;25.8,-2.08,;24.46,-2.85,;25.8,-.54,;24.46,.23,;23.13,-.54,;21.8,.23,;21.8,1.77,;20.46,-.54,;24.46,1.77,;25.8,2.54,;23.13,2.54,;23.13,4.08,;24.46,4.85,;24.46,6.39,;25.8,7.16,;23.13,7.16,;21.8,4.85,;21.8,6.39,;20.46,4.08,;20.3,2.55,;18.79,2.23,;18.02,3.57,;19.05,4.71,;18.73,6.22,;19.88,7.25,;17.27,6.69,;16.13,5.66,;16.45,4.16,;15.3,3.13,;15.62,1.62,;13.84,3.6,;14.66,6.14,;14.34,7.65,;13.52,5.11,;12.05,5.58,;11.73,7.09,;10.27,7.57,;9.95,9.07,;8.48,9.55,;8.16,11.06,;6.7,11.53,;9.31,12.09,;10.91,4.55,;11.23,3.05,;9.44,5.03,;8.3,4,;6.83,4.47,;5.69,3.44,;4.22,3.92,;3.08,2.89,;3.4,1.38,;4.86,.91,;6.01,1.94,;8.62,2.49,;7.47,1.46,;10.08,2.02,)| Show InChI InChI=1S/C64H96N18O12S/c1-36(2)28-45(57(88)74-43(20-13-24-71-64(68)69)55(86)75-44(53(67)84)30-39-16-9-7-10-17-39)78-61(92)51-22-15-26-82(51)63(94)49(29-37(3)4)80-59(90)48(33-52(66)83)76-54(85)38(5)73-56(87)46(31-40-18-11-8-12-19-40)77-58(89)47(32-41-34-70-35-72-41)79-60(91)50-21-14-25-81(50)62(93)42(65)23-27-95-6/h7-12,16-19,34-38,42-51H,13-15,20-33,65H2,1-6H3,(H2,66,83)(H2,67,84)(H,70,72)(H,73,87)(H,74,88)(H,75,86)(H,76,85)(H,77,89)(H,78,92)(H,79,91)(H,80,90)(H4,68,69,71)/t38-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-/m0/s1 | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86143
(L-Val-L-Pro-L-Asn-L-Leu-L-Pro-L-Gln-L-Arg-L-Phe-NH...)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7])-[#6](-[#6])-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C45H72N14O10/c1-24(2)21-31(57-40(65)30(23-35(47)61)56-42(67)33-15-10-20-59(33)44(69)36(48)25(3)4)43(68)58-19-9-14-32(58)41(66)54-28(16-17-34(46)60)39(64)53-27(13-8-18-52-45(50)51)38(63)55-29(37(49)62)22-26-11-6-5-7-12-26/h5-7,11-12,24-25,27-33,36H,8-10,13-23,48H2,1-4H3,(H2,46,60)(H2,47,61)(H2,49,62)(H,53,64)(H,54,66)(H,55,63)(H,56,67)(H,57,65)(H4,50,51,52)/t27-,28-,29-,30-,31-,32-,33-,36-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86139
(CAS_235433-36-0 | CAS_99566-27-5 | NPSF | NSC_0 | ...)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O |r| Show InChI InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86148
(CAS_222988-10-5 | PrRP20)Show SMILES CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |r,wU:31.40,57.60,77.81,101.106,89.92,111.115,96.101,98.104,125.131,151.156,wD:43.56,27.27,62.64,105.111,69.77,12.19,81.89,4.4,2.2,129.134,140.145,(11.09,9.04,;9.83,9.87,;8.5,9.19,;8.39,7.7,;7.21,10.07,;5.85,9.36,;5.77,7.85,;7.06,7,;4.44,7.12,;4.34,5.63,;3.08,4.78,;1.87,5.53,;3.05,3.19,;4.36,2.33,;5.77,3.06,;7.06,2.26,;8.39,2.96,;9.71,2.08,;11.09,2.81,;9.68,.54,;1.69,2.51,;1.51,1,;2.75,.16,;.1,.26,;.05,-1.27,;-1.31,-1.95,;-2.57,-1.1,;-1.39,-3.47,;-2.72,-4.12,;-2.72,-5.66,;-1.39,-6.52,;-4.11,-6.37,;-5.39,-5.51,;-5.32,-3.97,;-6.6,-3.14,;-6.45,-1.58,;-5.09,-.92,;-4.94,.64,;-3.83,-1.75,;-3.93,-3.34,;-4.16,-7.88,;-5.52,-8.56,;-6.81,-7.75,;-5.57,-10.1,;-4.29,-10.95,;-2.92,-10.2,;-2.77,-8.68,;-1.26,-8.31,;-.45,-9.67,;1.03,-10.02,;1.56,-11.53,;.45,-12.54,;-1.06,-12.34,;-1.56,-10.85,;-6.91,-10.8,;-6.93,-12.34,;-5.65,-13.2,;-8.27,-13.1,;-9.63,-12.24,;-8.37,-14.63,;-9.81,-15.21,;-11.14,-14.36,;-9.93,-16.68,;-8.77,-17.76,;-9.48,-19.17,;-11.02,-18.99,;-11.27,-17.46,;-12.68,-16.85,;-12.68,-15.42,;-13.96,-17.66,;-13.99,-19.2,;-12.6,-19.98,;-11.27,-19.17,;-12.6,-21.46,;-15.33,-16.85,;-16.71,-17.58,;-16.66,-19.1,;-18.05,-16.8,;-19.36,-17.58,;-20.67,-16.75,;-20.67,-15.21,;-22.01,-17.53,;-22.03,-19.12,;-20.67,-19.85,;-19.33,-19.07,;-20.67,-21.44,;-23.37,-16.78,;-24.65,-17.63,;-24.65,-19.3,;-25.99,-16.9,;-26.24,-15.39,;-27.78,-15.14,;-28.54,-16.55,;-27.38,-17.63,;-27.58,-19.2,;-26.37,-20.08,;-29.04,-19.8,;-29.19,-21.39,;-30.33,-18.87,;-31.76,-19.5,;-30.15,-17.33,;-18.05,-15.26,;-19.38,-14.46,;-16.71,-14.51,;-16.69,-12.92,;-.13,-4.3,;-.2,-5.81,;1.24,-3.62,;7.26,11.53,;6.05,12.36,;8.62,12.21,;8.65,13.7,;7.36,14.63,;7.44,16.2,;6.2,17.03,;6.28,18.57,;4.94,19.45,;5.04,21.01,;3.5,18.77,;10.08,14.48,;11.29,13.65,;10.31,15.99,;9.2,17.08,;9.93,18.46,;11.44,18.24,;11.7,16.75,;12.98,15.99,;12.98,14.41,;14.29,16.85,;15.6,16.1,;15.63,14.58,;14.32,13.75,;16.94,13.8,;16.89,16.88,;16.86,18.41,;18.2,16.12,;19.49,16.85,;20.85,16.12,;20.82,14.66,;22.21,16.8,;23.52,16.02,;23.49,14.43,;24.86,13.62,;24.83,12.14,;26.12,11.33,;26.09,9.79,;27.4,8.99,;24.78,9.01,;24.88,16.8,;24.88,18.26,;26.24,16.12,;27.6,16.85,;27.63,18.36,;28.99,19.2,;30.33,18.34,;31.74,19.12,;31.76,20.66,;30.45,21.46,;29.04,20.71,;28.89,16.12,;30.15,16.98,;28.86,14.48,)| Show InChI InChI=1S/C104H158N32O26/c1-10-53(5)82(97(158)124-66(29-19-39-116-104(112)113)99(160)134-40-21-32-74(134)94(155)131-81(52(3)4)95(156)119-49-77(142)123-65(28-18-38-115-103(110)111)88(149)125-67(85(107)146)43-58-23-13-12-14-24-58)130-78(143)51-118-87(148)64(27-17-37-114-102(108)109)122-76(141)50-120-96(157)84(57(9)138)133-90(151)68(44-59-33-35-61(139)36-34-59)127-89(150)69(45-60-48-117-63-26-16-15-25-62(60)63)126-86(147)55(7)121-92(153)72-30-20-41-135(72)100(161)71(46-75(105)140)129-98(159)83(54(6)11-2)132-91(152)70(47-79(144)145)128-93(154)73-31-22-42-136(73)101(162)80(106)56(8)137/h12-16,23-26,33-36,48,52-57,64-74,80-84,117,137-139H,10-11,17-22,27-32,37-47,49-51,106H2,1-9H3,(H2,105,140)(H2,107,146)(H,118,148)(H,119,156)(H,120,157)(H,121,153)(H,122,141)(H,123,142)(H,124,158)(H,125,149)(H,126,147)(H,127,150)(H,128,154)(H,129,159)(H,130,143)(H,131,155)(H,132,152)(H,133,151)(H,144,145)(H4,108,109,114)(H4,110,111,115)(H4,112,113,116)/t53-,54-,55-,56+,57+,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,80-,81-,82-,83-,84-/m0/s1 | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 23 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86146
(CAS_0 | NSC_0 | PrRP24-31)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7])-[#6](-[#6])-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O |r| Show InChI InChI=1S/C42H67N13O9/c1-23(2)19-29(53-37(60)28(21-32(43)56)52-39(62)31-15-10-18-55(31)41(64)34(44)24(3)4)40(63)54-17-9-14-30(54)38(61)49-22-33(57)50-26(13-8-16-48-42(46)47)36(59)51-27(35(45)58)20-25-11-6-5-7-12-25/h5-7,11-12,23-24,26-31,34H,8-10,13-22,44H2,1-4H3,(H2,43,56)(H2,45,58)(H,49,61)(H,50,57)(H,51,59)(H,52,62)(H,53,60)(H4,46,47,48)/t26-,27-,28-,29-,30-,31-,34-/m0/s1 | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86139
(CAS_235433-36-0 | CAS_99566-27-5 | NPSF | NSC_0 | ...)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O |r| Show InChI InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Prolactin-releasing peptide receptor
(Homo sapiens (Human)) | BDBM86146
(CAS_0 | NSC_0 | PrRP24-31)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7])-[#6](-[#6])-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O |r| Show InChI InChI=1S/C42H67N13O9/c1-23(2)19-29(53-37(60)28(21-32(43)56)52-39(62)31-15-10-18-55(31)41(64)34(44)24(3)4)40(63)54-17-9-14-30(54)38(61)49-22-33(57)50-26(13-8-16-48-42(46)47)36(59)51-27(35(45)58)20-25-11-6-5-7-12-25/h5-7,11-12,23-24,26-31,34H,8-10,13-22,44H2,1-4H3,(H2,43,56)(H2,45,58)(H,49,61)(H,50,57)(H,51,59)(H,52,62)(H,53,60)(H4,46,47,48)/t26-,27-,28-,29-,30-,31-,34-/m0/s1 | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 47 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86143
(L-Val-L-Pro-L-Asn-L-Leu-L-Pro-L-Gln-L-Arg-L-Phe-NH...)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7])-[#6](-[#6])-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C45H72N14O10/c1-24(2)21-31(57-40(65)30(23-35(47)61)56-42(67)33-15-10-20-59(33)44(69)36(48)25(3)4)43(68)58-19-9-14-32(58)41(66)54-28(16-17-34(46)60)39(64)53-27(13-8-18-52-45(50)51)38(63)55-29(37(49)62)22-26-11-6-5-7-12-26/h5-7,11-12,24-25,27-33,36H,8-10,13-23,48H2,1-4H3,(H2,46,60)(H2,47,61)(H2,49,62)(H,53,64)(H,54,66)(H,55,63)(H,56,67)(H,57,65)(H4,50,51,52)/t27-,28-,29-,30-,31-,32-,33-,36-/m0/s1 | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 55 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM84996
(BIBP3226 | CAS_5311023 | NSC_5311023)Show SMILES [#7]\[#6](-[#7])=[#7]\[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=O)-[#6](-c1ccccc1)-c1ccccc1)-[#6](=O)-[#7]-[#6]-c1ccc(-[#8])cc1 Show InChI InChI=1S/C27H31N5O3/c28-27(29)30-17-7-12-23(25(34)31-18-19-13-15-22(33)16-14-19)32-26(35)24(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h1-6,8-11,13-16,23-24,33H,7,12,17-18H2,(H,31,34)(H,32,35)(H4,28,29,30) | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 390 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM84996
(BIBP3226 | CAS_5311023 | NSC_5311023)Show SMILES [#7]\[#6](-[#7])=[#7]\[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=O)-[#6](-c1ccccc1)-c1ccccc1)-[#6](=O)-[#7]-[#6]-c1ccc(-[#8])cc1 Show InChI InChI=1S/C27H31N5O3/c28-27(29)30-17-7-12-23(25(34)31-18-19-13-15-22(33)16-14-19)32-26(35)24(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h1-6,8-11,13-16,23-24,33H,7,12,17-18H2,(H,31,34)(H,32,35)(H4,28,29,30) | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 640 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM82285
(NPY 18-36 | NPY18-36 | NPY18-36, porcine)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |wU:126.131,95.100,125.128,101.104,8.17,143.146,20.28,41.47,163.166,54.58,wD:117.120,109.112,84.95,4.4,132.135,72.84,30.39,152.155,60.71,118.122,2.2,49.51,(38.36,6.07,;37.02,5.3,;37.02,3.76,;38.36,2.99,;35.69,2.99,;35.69,1.45,;37.02,.68,;38.36,1.45,;37.02,-.86,;35.69,-1.63,;35.69,-3.17,;34.36,-3.94,;34.36,-5.48,;35.69,-6.25,;35.69,-7.79,;37.02,-5.48,;37.02,-3.94,;38.36,-1.63,;39.69,-.86,;39.69,.68,;41.02,-1.63,;41.02,-3.17,;42.36,-3.94,;43.76,-3.32,;44.8,-4.46,;44.03,-5.8,;42.52,-5.48,;42.36,-.86,;42.36,.68,;41.02,1.45,;43.13,2.01,;42.36,3.34,;43.13,4.68,;44.67,4.68,;45.44,6.01,;44.67,7.34,;45.44,8.68,;43.13,7.34,;44.67,2.01,;45.44,.68,;44.67,-.66,;46.98,.68,;47.75,-.66,;46.98,-1.99,;47.75,-3.32,;45.44,-1.99,;47.75,2.01,;49.29,2.01,;50.06,.68,;50.06,3.34,;49.29,4.68,;51.6,3.34,;52.37,4.68,;51.6,6.01,;53.91,4.68,;54.68,3.34,;56.22,3.34,;54.68,6.01,;56.22,6.01,;56.99,4.68,;56.99,7.34,;56.22,8.68,;56.99,10.01,;58.53,10.01,;59.3,11.35,;58.53,12.68,;59.3,14.01,;56.99,12.68,;56.22,11.35,;58.53,7.34,;59.3,6.01,;58.53,4.68,;60.84,6.01,;61.61,7.34,;63.15,7.34,;63.92,6.01,;65.46,6.01,;66.23,7.34,;67.77,7.34,;65.46,8.68,;63.92,8.68,;61.61,4.68,;60.84,3.34,;59.3,3.34,;61.61,2.01,;63.15,2.01,;63.92,.68,;65.46,.68,;66.23,-.66,;67.77,-.66,;68.54,-1.99,;68.54,.68,;60.84,.68,;61.61,-.66,;63.15,-.66,;60.84,-1.99,;59.3,-1.99,;61.61,-3.32,;34.36,3.76,;33.02,2.99,;34.36,5.3,;33.02,6.07,;32.03,4.89,;30.52,5.15,;29.53,3.97,;29.99,6.6,;33.02,7.61,;34.36,8.38,;32.03,8.79,;32.56,10.23,;34.08,10.5,;34.6,11.95,;36.12,12.22,;33.61,13.13,;31.57,11.41,;32.1,12.86,;30.05,11.15,;29.06,12.33,;29.59,13.77,;31.11,14.04,;28.6,14.95,;29.13,16.4,;27.55,12.06,;27.02,10.61,;26.56,13.24,;25.04,12.97,;24.51,11.52,;25.5,10.34,;23,11.26,;24.05,14.15,;24.58,15.6,;22.53,13.88,;21.54,15.06,;22.07,16.51,;21.08,17.69,;21.61,19.14,;20.62,20.32,;21.14,21.76,;20.15,22.94,;22.66,22.03,;20.03,14.8,;19.5,13.35,;19.04,15.97,;17.52,15.71,;16.99,14.26,;15.48,13.99,;14.95,12.55,;13.43,12.28,;15.94,11.37,;16.53,16.89,;17.06,18.33,;15.01,16.62,;14.02,17.8,;14.55,19.25,;13.56,20.43,;14.09,21.87,;13.1,23.05,;13.62,24.5,;12.63,25.68,;15.14,24.77,;12.51,17.53,;11.98,16.08,;11.52,18.71,;10,18.44,;9.47,17,;7.96,16.73,;6.97,17.91,;5.45,17.64,;4.92,16.19,;3.41,15.93,;5.91,15.02,;7.43,15.28,;9.01,19.62,;9.54,21.07,;7.49,19.36,)| Show InChI InChI=1S/C112H174N36O27/c1-12-57(7)87(106(173)144-83(51-86(115)156)102(169)139-78(45-56(5)6)103(170)147-88(58(8)13-2)107(174)148-89(61(11)150)108(175)136-74(21-17-43-129-112(123)124)93(160)135-75(38-39-85(114)155)97(164)133-72(19-15-41-127-110(119)120)94(161)137-76(90(116)157)46-62-22-30-67(151)31-23-62)146-104(171)81(49-65-28-36-70(154)37-29-65)142-101(168)82(50-66-52-125-54-130-66)143-96(163)73(20-16-42-128-111(121)122)134-98(165)77(44-55(3)4)138-92(159)60(10)131-105(172)84(53-149)145-100(167)80(48-64-26-34-69(153)35-27-64)141-99(166)79(47-63-24-32-68(152)33-25-63)140-95(162)71(132-91(158)59(9)113)18-14-40-126-109(117)118/h22-37,52,54-61,71-84,87-89,149-154H,12-21,38-51,53,113H2,1-11H3,(H2,114,155)(H2,115,156)(H2,116,157)(H,125,130)(H,131,172)(H,132,158)(H,133,164)(H,134,165)(H,135,160)(H,136,175)(H,137,161)(H,138,159)(H,139,169)(H,140,162)(H,141,166)(H,142,168)(H,143,163)(H,144,173)(H,145,167)(H,146,171)(H,147,170)(H,148,174)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)(H4,123,124,129)/t57-,58-,59-,60-,61+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,87-,88-,89-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 860 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM50015490
(CHEMBL438945 | H-YPSKPDNPGEDAPAEDMARYYSALRHYINLITR...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C189H285N55O57S/c1-15-93(7)148(179(295)234-128(81-140(193)254)168(284)226-123(74-92(5)6)171(287)239-149(94(8)16-2)180(296)240-150(99(13)247)181(297)222-115(31-22-67-208-189(202)203)156(272)220-117(56-59-139(192)253)161(277)218-113(29-20-65-206-187(198)199)157(273)224-121(151(195)267)76-101-38-48-107(249)49-39-101)238-172(288)126(79-104-44-54-110(252)55-45-104)229-167(283)127(80-105-86-204-90-210-105)230-159(275)114(30-21-66-207-188(200)201)219-164(280)122(73-91(3)4)225-154(270)96(10)212-173(289)133(88-245)236-166(282)125(78-103-42-52-109(251)53-43-103)228-165(281)124(77-102-40-50-108(250)51-41-102)227-158(274)112(28-19-64-205-186(196)197)216-152(268)95(9)211-155(271)119(62-72-302-14)221-169(285)130(84-146(263)264)232-162(278)118(58-61-144(259)260)217-153(269)97(11)213-176(292)136-33-24-68-241(136)182(298)98(12)214-163(279)129(83-145(261)262)231-160(276)116(57-60-143(257)258)215-142(256)87-209-175(291)135-32-23-70-243(135)185(301)132(82-141(194)255)235-170(286)131(85-147(265)266)233-177(293)138-35-26-71-244(138)184(300)120(27-17-18-63-190)223-174(290)134(89-246)237-178(294)137-34-25-69-242(137)183(299)111(191)75-100-36-46-106(248)47-37-100/h36-55,86,90-99,111-138,148-150,245-252H,15-35,56-85,87-89,190-191H2,1-14H3,(H2,192,253)(H2,193,254)(H2,194,255)(H2,195,267)(H,204,210)(H,209,291)(H,211,271)(H,212,289)(H,213,292)(H,214,279)(H,215,256)(H,216,268)(H,217,269)(H,218,277)(H,219,280)(H,220,272)(H,221,285)(H,222,297)(H,223,290)(H,224,273)(H,225,270)(H,226,284)(H,227,274)(H,228,281)(H,229,283)(H,230,275)(H,231,276)(H,232,278)(H,233,293)(H,234,295)(H,235,286)(H,236,282)(H,237,294)(H,238,288)(H,239,287)(H,240,296)(H,257,258)(H,259,260)(H,261,262)(H,263,264)(H,265,266)(H4,196,197,205)(H4,198,199,206)(H4,200,201,207)(H4,202,203,208)/t93-,94-,95-,96-,97-,98-,99+,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,148-,149-,150-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 920 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM82285
(NPY 18-36 | NPY18-36 | NPY18-36, porcine)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |wU:126.131,95.100,125.128,101.104,8.17,143.146,20.28,41.47,163.166,54.58,wD:117.120,109.112,84.95,4.4,132.135,72.84,30.39,152.155,60.71,118.122,2.2,49.51,(38.36,6.07,;37.02,5.3,;37.02,3.76,;38.36,2.99,;35.69,2.99,;35.69,1.45,;37.02,.68,;38.36,1.45,;37.02,-.86,;35.69,-1.63,;35.69,-3.17,;34.36,-3.94,;34.36,-5.48,;35.69,-6.25,;35.69,-7.79,;37.02,-5.48,;37.02,-3.94,;38.36,-1.63,;39.69,-.86,;39.69,.68,;41.02,-1.63,;41.02,-3.17,;42.36,-3.94,;43.76,-3.32,;44.8,-4.46,;44.03,-5.8,;42.52,-5.48,;42.36,-.86,;42.36,.68,;41.02,1.45,;43.13,2.01,;42.36,3.34,;43.13,4.68,;44.67,4.68,;45.44,6.01,;44.67,7.34,;45.44,8.68,;43.13,7.34,;44.67,2.01,;45.44,.68,;44.67,-.66,;46.98,.68,;47.75,-.66,;46.98,-1.99,;47.75,-3.32,;45.44,-1.99,;47.75,2.01,;49.29,2.01,;50.06,.68,;50.06,3.34,;49.29,4.68,;51.6,3.34,;52.37,4.68,;51.6,6.01,;53.91,4.68,;54.68,3.34,;56.22,3.34,;54.68,6.01,;56.22,6.01,;56.99,4.68,;56.99,7.34,;56.22,8.68,;56.99,10.01,;58.53,10.01,;59.3,11.35,;58.53,12.68,;59.3,14.01,;56.99,12.68,;56.22,11.35,;58.53,7.34,;59.3,6.01,;58.53,4.68,;60.84,6.01,;61.61,7.34,;63.15,7.34,;63.92,6.01,;65.46,6.01,;66.23,7.34,;67.77,7.34,;65.46,8.68,;63.92,8.68,;61.61,4.68,;60.84,3.34,;59.3,3.34,;61.61,2.01,;63.15,2.01,;63.92,.68,;65.46,.68,;66.23,-.66,;67.77,-.66,;68.54,-1.99,;68.54,.68,;60.84,.68,;61.61,-.66,;63.15,-.66,;60.84,-1.99,;59.3,-1.99,;61.61,-3.32,;34.36,3.76,;33.02,2.99,;34.36,5.3,;33.02,6.07,;32.03,4.89,;30.52,5.15,;29.53,3.97,;29.99,6.6,;33.02,7.61,;34.36,8.38,;32.03,8.79,;32.56,10.23,;34.08,10.5,;34.6,11.95,;36.12,12.22,;33.61,13.13,;31.57,11.41,;32.1,12.86,;30.05,11.15,;29.06,12.33,;29.59,13.77,;31.11,14.04,;28.6,14.95,;29.13,16.4,;27.55,12.06,;27.02,10.61,;26.56,13.24,;25.04,12.97,;24.51,11.52,;25.5,10.34,;23,11.26,;24.05,14.15,;24.58,15.6,;22.53,13.88,;21.54,15.06,;22.07,16.51,;21.08,17.69,;21.61,19.14,;20.62,20.32,;21.14,21.76,;20.15,22.94,;22.66,22.03,;20.03,14.8,;19.5,13.35,;19.04,15.97,;17.52,15.71,;16.99,14.26,;15.48,13.99,;14.95,12.55,;13.43,12.28,;15.94,11.37,;16.53,16.89,;17.06,18.33,;15.01,16.62,;14.02,17.8,;14.55,19.25,;13.56,20.43,;14.09,21.87,;13.1,23.05,;13.62,24.5,;12.63,25.68,;15.14,24.77,;12.51,17.53,;11.98,16.08,;11.52,18.71,;10,18.44,;9.47,17,;7.96,16.73,;6.97,17.91,;5.45,17.64,;4.92,16.19,;3.41,15.93,;5.91,15.02,;7.43,15.28,;9.01,19.62,;9.54,21.07,;7.49,19.36,)| Show InChI InChI=1S/C112H174N36O27/c1-12-57(7)87(106(173)144-83(51-86(115)156)102(169)139-78(45-56(5)6)103(170)147-88(58(8)13-2)107(174)148-89(61(11)150)108(175)136-74(21-17-43-129-112(123)124)93(160)135-75(38-39-85(114)155)97(164)133-72(19-15-41-127-110(119)120)94(161)137-76(90(116)157)46-62-22-30-67(151)31-23-62)146-104(171)81(49-65-28-36-70(154)37-29-65)142-101(168)82(50-66-52-125-54-130-66)143-96(163)73(20-16-42-128-111(121)122)134-98(165)77(44-55(3)4)138-92(159)60(10)131-105(172)84(53-149)145-100(167)80(48-64-26-34-69(153)35-27-64)141-99(166)79(47-63-24-32-68(152)33-25-63)140-95(162)71(132-91(158)59(9)113)18-14-40-126-109(117)118/h22-37,52,54-61,71-84,87-89,149-154H,12-21,38-51,53,113H2,1-11H3,(H2,114,155)(H2,115,156)(H2,116,157)(H,125,130)(H,131,172)(H,132,158)(H,133,164)(H,134,165)(H,135,160)(H,136,175)(H,137,161)(H,138,159)(H,139,169)(H,140,162)(H,141,166)(H,142,168)(H,143,163)(H,144,173)(H,145,167)(H,146,171)(H,147,170)(H,148,174)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)(H4,123,124,129)/t57-,58-,59-,60-,61+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,87-,88-,89-/m0/s1 | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Pro-FMRFamide-related neuropeptide FF
(RAT) | BDBM86144
(CAS_0 | NPFF-OH | NSC_0)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#8])=O |r| Show InChI InChI=1S/C54H75N13O11/c1-32(2)28-40(64-46(70)36(55)29-33-14-6-3-7-15-33)49(73)65-41(30-34-16-8-4-9-17-34)50(74)63-39(23-25-45(57)69)52(76)67-27-13-21-43(67)51(75)62-38(22-24-44(56)68)48(72)61-37(20-12-26-60-54(58)59)47(71)66-42(53(77)78)31-35-18-10-5-11-19-35/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,68)(H2,57,69)(H,61,72)(H,62,75)(H,63,74)(H,64,70)(H,65,73)(H,66,71)(H,77,78)(H4,58,59,60)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(RAT) | BDBM50015490
(CHEMBL438945 | H-YPSKPDNPGEDAPAEDMARYYSALRHYINLITR...)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O Show InChI InChI=1S/C189H285N55O57S/c1-15-93(7)148(179(295)234-128(81-140(193)254)168(284)226-123(74-92(5)6)171(287)239-149(94(8)16-2)180(296)240-150(99(13)247)181(297)222-115(31-22-67-208-189(202)203)156(272)220-117(56-59-139(192)253)161(277)218-113(29-20-65-206-187(198)199)157(273)224-121(151(195)267)76-101-38-48-107(249)49-39-101)238-172(288)126(79-104-44-54-110(252)55-45-104)229-167(283)127(80-105-86-204-90-210-105)230-159(275)114(30-21-66-207-188(200)201)219-164(280)122(73-91(3)4)225-154(270)96(10)212-173(289)133(88-245)236-166(282)125(78-103-42-52-109(251)53-43-103)228-165(281)124(77-102-40-50-108(250)51-41-102)227-158(274)112(28-19-64-205-186(196)197)216-152(268)95(9)211-155(271)119(62-72-302-14)221-169(285)130(84-146(263)264)232-162(278)118(58-61-144(259)260)217-153(269)97(11)213-176(292)136-33-24-68-241(136)182(298)98(12)214-163(279)129(83-145(261)262)231-160(276)116(57-60-143(257)258)215-142(256)87-209-175(291)135-32-23-70-243(135)185(301)132(82-141(194)255)235-170(286)131(85-147(265)266)233-177(293)138-35-26-71-244(138)184(300)120(27-17-18-63-190)223-174(290)134(89-246)237-178(294)137-34-25-69-242(137)183(299)111(191)75-100-36-46-106(248)47-37-100/h36-55,86,90-99,111-138,148-150,245-252H,15-35,56-85,87-89,190-191H2,1-14H3,(H2,192,253)(H2,193,254)(H2,194,255)(H2,195,267)(H,204,210)(H,209,291)(H,211,271)(H,212,289)(H,213,292)(H,214,279)(H,215,256)(H,216,268)(H,217,269)(H,218,277)(H,219,280)(H,220,272)(H,221,285)(H,222,297)(H,223,290)(H,224,273)(H,225,270)(H,226,284)(H,227,274)(H,228,281)(H,229,283)(H,230,275)(H,231,276)(H,232,278)(H,233,293)(H,234,295)(H,235,286)(H,236,282)(H,237,294)(H,238,288)(H,239,287)(H,240,296)(H,257,258)(H,259,260)(H,261,262)(H,263,264)(H,265,266)(H4,196,197,205)(H4,198,199,206)(H4,200,201,207)(H4,202,203,208)/t93-,94-,95-,96-,97-,98-,99+,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,127-,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,138-,148-,149-,150-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Neuropeptide FF receptor 2
(Homo sapiens (Human)) | BDBM86144
(CAS_0 | NPFF-OH | NSC_0)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@@H](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](/[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#8])=O |r| Show InChI InChI=1S/C54H75N13O11/c1-32(2)28-40(64-46(70)36(55)29-33-14-6-3-7-15-33)49(73)65-41(30-34-16-8-4-9-17-34)50(74)63-39(23-25-45(57)69)52(76)67-27-13-21-43(67)51(75)62-38(22-24-44(56)68)48(72)61-37(20-12-26-60-54(58)59)47(71)66-42(53(77)78)31-35-18-10-5-11-19-35/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,68)(H2,57,69)(H,61,72)(H,62,75)(H,63,74)(H,64,70)(H,65,73)(H,66,71)(H,77,78)(H4,58,59,60)/t36-,37-,38-,39-,40-,41-,42-,43-/m0/s1 | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 4.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Prolactin-releasing peptide receptor
(Homo sapiens (Human)) | BDBM82285
(NPY 18-36 | NPY18-36 | NPY18-36, porcine)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O |wU:126.131,95.100,125.128,101.104,8.17,143.146,20.28,41.47,163.166,54.58,wD:117.120,109.112,84.95,4.4,132.135,72.84,30.39,152.155,60.71,118.122,2.2,49.51,(38.36,6.07,;37.02,5.3,;37.02,3.76,;38.36,2.99,;35.69,2.99,;35.69,1.45,;37.02,.68,;38.36,1.45,;37.02,-.86,;35.69,-1.63,;35.69,-3.17,;34.36,-3.94,;34.36,-5.48,;35.69,-6.25,;35.69,-7.79,;37.02,-5.48,;37.02,-3.94,;38.36,-1.63,;39.69,-.86,;39.69,.68,;41.02,-1.63,;41.02,-3.17,;42.36,-3.94,;43.76,-3.32,;44.8,-4.46,;44.03,-5.8,;42.52,-5.48,;42.36,-.86,;42.36,.68,;41.02,1.45,;43.13,2.01,;42.36,3.34,;43.13,4.68,;44.67,4.68,;45.44,6.01,;44.67,7.34,;45.44,8.68,;43.13,7.34,;44.67,2.01,;45.44,.68,;44.67,-.66,;46.98,.68,;47.75,-.66,;46.98,-1.99,;47.75,-3.32,;45.44,-1.99,;47.75,2.01,;49.29,2.01,;50.06,.68,;50.06,3.34,;49.29,4.68,;51.6,3.34,;52.37,4.68,;51.6,6.01,;53.91,4.68,;54.68,3.34,;56.22,3.34,;54.68,6.01,;56.22,6.01,;56.99,4.68,;56.99,7.34,;56.22,8.68,;56.99,10.01,;58.53,10.01,;59.3,11.35,;58.53,12.68,;59.3,14.01,;56.99,12.68,;56.22,11.35,;58.53,7.34,;59.3,6.01,;58.53,4.68,;60.84,6.01,;61.61,7.34,;63.15,7.34,;63.92,6.01,;65.46,6.01,;66.23,7.34,;67.77,7.34,;65.46,8.68,;63.92,8.68,;61.61,4.68,;60.84,3.34,;59.3,3.34,;61.61,2.01,;63.15,2.01,;63.92,.68,;65.46,.68,;66.23,-.66,;67.77,-.66,;68.54,-1.99,;68.54,.68,;60.84,.68,;61.61,-.66,;63.15,-.66,;60.84,-1.99,;59.3,-1.99,;61.61,-3.32,;34.36,3.76,;33.02,2.99,;34.36,5.3,;33.02,6.07,;32.03,4.89,;30.52,5.15,;29.53,3.97,;29.99,6.6,;33.02,7.61,;34.36,8.38,;32.03,8.79,;32.56,10.23,;34.08,10.5,;34.6,11.95,;36.12,12.22,;33.61,13.13,;31.57,11.41,;32.1,12.86,;30.05,11.15,;29.06,12.33,;29.59,13.77,;31.11,14.04,;28.6,14.95,;29.13,16.4,;27.55,12.06,;27.02,10.61,;26.56,13.24,;25.04,12.97,;24.51,11.52,;25.5,10.34,;23,11.26,;24.05,14.15,;24.58,15.6,;22.53,13.88,;21.54,15.06,;22.07,16.51,;21.08,17.69,;21.61,19.14,;20.62,20.32,;21.14,21.76,;20.15,22.94,;22.66,22.03,;20.03,14.8,;19.5,13.35,;19.04,15.97,;17.52,15.71,;16.99,14.26,;15.48,13.99,;14.95,12.55,;13.43,12.28,;15.94,11.37,;16.53,16.89,;17.06,18.33,;15.01,16.62,;14.02,17.8,;14.55,19.25,;13.56,20.43,;14.09,21.87,;13.1,23.05,;13.62,24.5,;12.63,25.68,;15.14,24.77,;12.51,17.53,;11.98,16.08,;11.52,18.71,;10,18.44,;9.47,17,;7.96,16.73,;6.97,17.91,;5.45,17.64,;4.92,16.19,;3.41,15.93,;5.91,15.02,;7.43,15.28,;9.01,19.62,;9.54,21.07,;7.49,19.36,)| Show InChI InChI=1S/C112H174N36O27/c1-12-57(7)87(106(173)144-83(51-86(115)156)102(169)139-78(45-56(5)6)103(170)147-88(58(8)13-2)107(174)148-89(61(11)150)108(175)136-74(21-17-43-129-112(123)124)93(160)135-75(38-39-85(114)155)97(164)133-72(19-15-41-127-110(119)120)94(161)137-76(90(116)157)46-62-22-30-67(151)31-23-62)146-104(171)81(49-65-28-36-70(154)37-29-65)142-101(168)82(50-66-52-125-54-130-66)143-96(163)73(20-16-42-128-111(121)122)134-98(165)77(44-55(3)4)138-92(159)60(10)131-105(172)84(53-149)145-100(167)80(48-64-26-34-69(153)35-27-64)141-99(166)79(47-63-24-32-68(152)33-25-63)140-95(162)71(132-91(158)59(9)113)18-14-40-126-109(117)118/h22-37,52,54-61,71-84,87-89,149-154H,12-21,38-51,53,113H2,1-11H3,(H2,114,155)(H2,115,156)(H2,116,157)(H,125,130)(H,131,172)(H,132,158)(H,133,164)(H,134,165)(H,135,160)(H,136,175)(H,137,161)(H,138,159)(H,139,169)(H,140,162)(H,141,166)(H,142,168)(H,143,163)(H,144,173)(H,145,167)(H,146,171)(H,147,170)(H,148,174)(H4,117,118,126)(H4,119,120,127)(H4,121,122,128)(H4,123,124,129)/t57-,58-,59-,60-,61+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,87-,88-,89-/m0/s1 | UniProtKB/SwissProt
GoogleScholar
AffyNet
| KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 7.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Prolactin-releasing peptide receptor
(Homo sapiens (Human)) | BDBM86145
(L-Met-L-Pro-L-His-L-Serr-L-Phe-L-Ala-L-Asn-L-Leu-L...)Show SMILES CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O |wU:61.65,65.68,42.44,26.27,16.16,12.13,4.4,wD:50.52,73.76,37.40,84.87,(38.04,3.65,;37.72,2.14,;36.25,1.67,;35.93,.16,;34.47,-.32,;33.33,.71,;34.15,-1.82,;32.68,-2.3,;35.29,-2.85,;36.8,-2.53,;37.57,-3.87,;36.54,-5.01,;35.13,-4.39,;33.8,-5.16,;32.47,-4.39,;33.8,-6.7,;32.47,-7.47,;32.47,-9.01,;33.8,-9.78,;33.96,-11.31,;35.47,-11.63,;36.24,-10.29,;35.21,-9.15,;31.13,-6.7,;31.13,-5.16,;29.8,-7.47,;28.46,-6.7,;27.13,-7.47,;27.13,-9.01,;25.8,-9.78,;25.8,-11.32,;27.13,-12.09,;28.46,-11.32,;28.46,-9.78,;28.46,-5.16,;29.8,-4.39,;27.13,-4.39,;27.13,-2.85,;28.46,-2.08,;25.8,-2.08,;24.46,-2.85,;25.8,-.54,;24.46,.23,;23.13,-.54,;21.8,.23,;21.8,1.77,;20.46,-.54,;24.46,1.77,;25.8,2.54,;23.13,2.54,;23.13,4.08,;24.46,4.85,;24.46,6.39,;25.8,7.16,;23.13,7.16,;21.8,4.85,;21.8,6.39,;20.46,4.08,;20.3,2.55,;18.79,2.23,;18.02,3.57,;19.05,4.71,;18.73,6.22,;19.88,7.25,;17.27,6.69,;16.13,5.66,;16.45,4.16,;15.3,3.13,;15.62,1.62,;13.84,3.6,;14.66,6.14,;14.34,7.65,;13.52,5.11,;12.05,5.58,;11.73,7.09,;10.27,7.57,;9.95,9.07,;8.48,9.55,;8.16,11.06,;6.7,11.53,;9.31,12.09,;10.91,4.55,;11.23,3.05,;9.44,5.03,;8.3,4,;6.83,4.47,;5.69,3.44,;4.22,3.92,;3.08,2.89,;3.4,1.38,;4.86,.91,;6.01,1.94,;8.62,2.49,;7.47,1.46,;10.08,2.02,)| Show InChI InChI=1S/C64H96N18O12S/c1-36(2)28-45(57(88)74-43(20-13-24-71-64(68)69)55(86)75-44(53(67)84)30-39-16-9-7-10-17-39)78-61(92)51-22-15-26-82(51)63(94)49(29-37(3)4)80-59(90)48(33-52(66)83)76-54(85)38(5)73-56(87)46(31-40-18-11-8-12-19-40)77-58(89)47(32-41-34-70-35-72-41)79-60(91)50-21-14-25-81(50)62(93)42(65)23-27-95-6/h7-12,16-19,34-38,42-51H,13-15,20-33,65H2,1-6H3,(H2,66,83)(H2,67,84)(H,70,72)(H,73,87)(H,74,88)(H,75,86)(H,76,85)(H,77,89)(H,78,92)(H,79,91)(H,80,90)(H4,68,69,71)/t38-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-/m0/s1 | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Prolactin-releasing peptide receptor
(Homo sapiens (Human)) | BDBM86140
(CAS_123797 | NPFF | NSC_123797)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6](-[#7]-[#6](=O)-[#6](-[#7])-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6]-1-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C54H76N14O10/c1-32(2)28-41(66-47(72)36(55)29-33-14-6-3-7-15-33)50(75)67-42(31-35-18-10-5-11-19-35)51(76)64-39(23-25-45(57)70)53(78)68-27-13-21-43(68)52(77)63-38(22-24-44(56)69)49(74)62-37(20-12-26-61-54(59)60)48(73)65-40(46(58)71)30-34-16-8-4-9-17-34/h3-11,14-19,32,36-43H,12-13,20-31,55H2,1-2H3,(H2,56,69)(H2,57,70)(H2,58,71)(H,62,74)(H,63,77)(H,64,76)(H,65,73)(H,66,72)(H,67,75)(H4,59,60,61) | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Prolactin-releasing peptide receptor
(Homo sapiens (Human)) | BDBM84996
(BIBP3226 | CAS_5311023 | NSC_5311023)Show SMILES [#7]\[#6](-[#7])=[#7]\[#6]-[#6]-[#6]-[#6](-[#7]-[#6](=O)-[#6](-c1ccccc1)-c1ccccc1)-[#6](=O)-[#7]-[#6]-c1ccc(-[#8])cc1 Show InChI InChI=1S/C27H31N5O3/c28-27(29)30-17-7-12-23(25(34)31-18-19-13-15-22(33)16-14-19)32-26(35)24(20-8-3-1-4-9-20)21-10-5-2-6-11-21/h1-6,8-11,13-16,23-24,33H,7,12,17-18H2,(H,31,34)(H,32,35)(H4,28,29,30) | UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Prolactin-releasing peptide receptor
(Homo sapiens (Human)) | BDBM86143
(L-Val-L-Pro-L-Asn-L-Leu-L-Pro-L-Gln-L-Arg-L-Phe-NH...)Show SMILES [#6]-[#6](-[#6])-[#6]-[#6@H](-[#7]-[#6](=O)-[#6@H](-[#6]-[#6](-[#7])=O)-[#7]-[#6](=O)-[#6@@H]-1-[#6]-[#6]-[#6]-[#7]-1-[#6](=O)-[#6@@H](-[#7])-[#6](-[#6])-[#6])-[#6](=O)-[#7]-1-[#6]-[#6]-[#6]-[#6@H]-1-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6](-[#7])=O)-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-c1ccccc1)-[#6](-[#7])=O Show InChI InChI=1S/C45H72N14O10/c1-24(2)21-31(57-40(65)30(23-35(47)61)56-42(67)33-15-10-20-59(33)44(69)36(48)25(3)4)43(68)58-19-9-14-32(58)41(66)54-28(16-17-34(46)60)39(64)53-27(13-8-18-52-45(50)51)38(63)55-29(37(49)62)22-26-11-6-5-7-12-26/h5-7,11-12,24-25,27-33,36H,8-10,13-23,48H2,1-4H3,(H2,46,60)(H2,47,61)(H2,49,62)(H,53,64)(H,54,66)(H,55,63)(H,56,67)(H,57,65)(H4,50,51,52)/t27-,28-,29-,30-,31-,32-,33-,36-/m0/s1 | UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Juvantia Pharma, Ltd.
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 305: 825-32 (2003)
Article DOI: 10.1124/jpet.102.047118
BindingDB Entry DOI: 10.7270/Q2WS8RS2 |
More data for this
Ligand-Target Pair | |
Search and Browse
